Guinea-Bissau vs Sudan: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%)
Guinea-Bissau
65.0%
in 2025
Sudan
72.0%
in 2025
Guinea-Bissau rank
8th
Sudan rank
5th
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) over time
- Guinea-Bissau
- Sudan
How they compare
Sudan currently reports 72.0% against 65.0% in Guinea-Bissau, a difference of 7.0%.
That makes Sudan's figure about 1.1 times Guinea-Bissau's.
The two have swapped places 2 times across 10 shared years of data; in 2016 it was Sudan ahead.
Guinea-Bissau ranks 8th and Sudan ranks 5th of 26 countries.
Sudan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 73.2% | 73.2% | Sudan |
| 2020s | 28.3% | 68.2% | 39.8% | Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher meningococcal a conjugate (menga) vaccine immunization coverage (%), Guinea-Bissau or Sudan?
- Sudan, at 72.0% against 65.0% in Guinea-Bissau as of 2025.
- What is the difference in meningococcal a conjugate (menga) vaccine immunization coverage (%) between Guinea-Bissau and Sudan?
- 7.0%, with Sudan ahead.
- How many years of comparable data are there for Guinea-Bissau and Sudan?
- 10 years are reported by both, from 2016 to 2025.
- How do Guinea-Bissau and Sudan rank globally for meningococcal a conjugate (menga) vaccine immunization coverage (%)?
- Guinea-Bissau ranks 8th and Sudan ranks 5th of 26 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.